# Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

> **NCT00668343** · PHASE3 · COMPLETED · sponsor: **Tehran University of Medical Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Relapsing Remitting Multiple Sclerosis

## Interventions

- **DRUG:** simvastatin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00668343
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-03
- **Final completion:** 2009-03
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00668343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00668343, "Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00668343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*